Transparent Tribe uses AI tools to mass-produce polyglot malware targeting India using Slack, Discord, and Google Sheets C2.

Over the course of nearly 300 posts, Jonathan Bennett set a very high bar for this column, so we knew it needed to be placed in the hands of somebody who could do it justice.

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Why Tiny Downloads Matter Again Modern web games can be massive, but the fastest experiences still start with a small download. A 13KB limit is famous because it forces a game to load almost instantly ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Looking for ways to make some extra money this year? We've compiled a list of different passive income ideas to spark inspiration, including investing, real estate and a few niche options, like ...

Dubbed InstallFix by Push Security, the scheme inserts instructions to download malware during the Claude Code install process on cloned websites.

Digital retail finance, personal finance and payments industry which offers access to point of sale credit and digital payment services, connecting customers with its network of merchants and offers ...

Self-RAG (Figure right) is a new framework to train an arbitrary LM to learn to retrieve, generate, and critique to enhance the factuality and quality of generations, without hurting the versatility ...

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year. 2025 was a slow year for IPOs, with ...